RS
ASND icon

R Squared’s Ascendis Pharma A/S ASND Stock Holding History

R Squared’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,212
Closed -$209K – 555
2025
Q2 		$209K Buy
+1,212
New +$197K 0.12% 297

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

R Squared's ASND Position: Q3 2025 in Review

R Squared sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 1,212 shares — an estimated $209K sold.

R Squared first reported a position in ASND in Q2 2025 and held it in 1 quarter. The position peaked at $209K in Q2 2025. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • R Squared reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • R Squared sold 1,212 Ascendis Pharma A/S shares in Q3 2025, an estimated $209K.
  • R Squared first reported a position in Ascendis Pharma A/S in Q2 2025 and held it in 1 quarter.
  • R Squared's Ascendis Pharma A/S position peaked at $209K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.